Article Information
History
- October 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julien Bryois1,*,
- Daniela Calini1,
- Will Macnair1,
- Lynette Foo1,
- Eduard Urich1,
- Ward Ortmann2,
- Victor Alejandro Iglesias2,
- Suresh Selvaraj2,
- Erik Nutma3,
- Manuel Marzin3,
- Sandra Amor3,4,
- Anna Williams5,
- Gonçalo Castelo-Branco6,7,
- Vilas Menon8,
- Philip De Jager8,9 and
- Dheeraj Malhotra1
- 1Neuroscience and Rare Diseases (NRD), F. Hoffmann-La Roche Ltd, Grenzacherstrasse, Basel, Switzerland
- 2Genentech, South San Francisco, California, USA
- 3Pathology Department, VUmc, Amsterdam UMC, Amsterdam, The Netherlands
- 4Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom
- 5Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, EH16 4UU, UK
- 6Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- 7Ming Wai Lau Centre for Reparative Medicine, Stockholm node, Karolinska Institutet, Stockholm, Sweden
- 8Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center, New York, USA
- 9Columbia Multiple Sclerosis Center, Department of Neurology, Columbia University Irving Medical Center, New York, USA
- ↵*Corresponding author; email: julien.bryois{at}gmail.com
Posted October 14, 2021.
Cell-type specific cis-eQTLs in eight brain cell-types identifies novel risk genes for human brain disorders
